Fueling The Growth Of Varicose Vein Treatment Devices Market

According to the report, the global varicose vein treatment market was valued at ~US$ 1.5 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=11714Varicose vein is one of the common diseases caused due to damage to the vein valves.

Endovenous ablation is a less-invasive treatment option for varicose veins.In terms of treatment type, the supportive treatments segment accounted for a major share of the global varicose vein treatment market in 2018.

Moreover, increase in awareness about ablation devices is expected to fuel the growth of the segment.

Based on end user, the hospitals & ambulatory surgical centers segment accounted for a major share of the market, due to the availability of services and rise in the rate of hospitalization.

Moreover, the preference for ambulatory surgical centers due to short hospital stays is likely fuel the growth of the segment.Request COVID Analysis on Varicose Vein Treatment Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=11714Global Varicose Vein Treatment Market: Prominent RegionsNorth America held a major share of the global varicose vein treatment market in 2018.

According to the American Heart Association, Inc., the prevalence of reticular vein and spider telangiectasias is higher in women in the U.S. Europe held the second-largest share of the global varicose vein treatment market in 2018.

This research study involved the extensive use of secondary sources, directories, and databases (such as Hoovers, Bloomberg Business, Factiva, and Avention) to identify and collect information useful for this technology-based, market-oriented, and commercial study of the North America and Europe varicose vein treatment market.

In-depth interviews were conducted with various primary respondents that mainly included key industry participants, subject-matter experts (SMEs), C & D level executives of key market players, and independent industry consultants, among others; to obtain and verify critical qualitative and quantitative information as well as to assess future market prospects of the varicose vein treatment industry.Major Growth Drivers:Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, and huge burden of varicose vein cases in North America and Europe is driving the growth of the market.

Other growth factors include improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.Expected Revenue Growth:The global market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22524107Accessories to Fuel the Growth of Varicose Vein Treatment MarketHowever, dearth of training for vascular surgeons, high cost of varicose vein treatment procedures, and implementation of healthcare reforms in the U.S. are some of the key factors restraining the growth of market.

In addition to this, challenges associated with inconsistent reimbursement scenario for varicose vein treatment procedures and sustainability of players in the highly competitive market also limits the growth of the market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22524107This report broadly segments the Varicose Vein Treatment market into mode of treatment and products.

On the basis of mode of treatment, the market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping.

The endovenous ablation segment is expected to command the major share of the market, by mode of treatment, in 2016.Based on type of products, the market is segmented into ablation devices, venous closure products, and surgical products.

The global market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.

Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, and huge burden of varicose vein cases in North America and Europe is driving the growth of the market.

Other growth factors include improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22524107According to the new market research report “Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021", published by MarketsandMarkets™, The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.Varicose Vein Treatment Market segmented into :+ On the basis of mode of treatment, the market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping.

The endovenous ablation segment is expected to command the major share of the market, by mode of treatment, in 2016.+ Based on type of products, the market is segmented into ablation devices, venous closure products, and surgical products.

The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices.+ This report covers the market across two major geographies, namely, North America and Europe.

In this report, the North American market is further segmented into the U.S. and Canada, while the European market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe.

 UpMarketResearch offers a latest published report on “Global Varicose Vein Treatment Devices Market Industry Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report.

The report contains 140 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.

It presents a comparative detailed analysis of all the regional and major player segments, offering readers a better knowledge of areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the global market.

The numerical data is backed up by statistical tools such as SWOT analysis, BCG matrix, SCOT analysis, PESTLE analysis and so on.

The statistics are represented in graphical format for a clear understanding on facts and figures.

The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.

Varicose veins are a common issue that affects close to 20% of adults.

Many people wonder, “Are varicose veins dangerous?” While varicose veins are not necessarily dangerous, they can lead to other complications if they are ignored.

Thankfully, treating varicose veins doesn’t have to be a stressful experience.

Varicose Veins Market Treatment Analysis By Type (Sclerotherapy, Endovenous Ablation, Lase Ablations, Stripping and Surgical Ligation), Product, End User and Regional Outlook, Forecast to 2023

Pune, India – July 18, 2019 —

The global varicose veins treatment market has been predicted to hold a market worth of USD 415.9 million in the year 2017 and is likely to grow at a CAGR of 7.4% over the forecast period (2018-2023).

Varicose veins are enlarged, knotted veins.

This happens since walking and standing augments the pressure in the veins of the lower body.

The growing demand for less invasive treatment facilities, growing prevalence of varicose veins, increasing investments by major market players and surging awareness about varicose veins is likely to propel the market growth over the forecast period.